IRODALOM
1. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA.: Recurrence and outcomes
following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann.
Surg. 2004 Jun;239(6):818-25; discussion 825-7.
2. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O,
Levi F,: Bismuth Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to
predict long-term survival. Ann. Surg. 2004 Oct;240(4):644-57; discussion 657-8.
3. Adam R, Lucidi V, Bismuth H.: Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am.
2004 Apr;84(2):659-71. Review.
4. Ahlman H, Nilsson O, Olausson M.: Interventional treatment of the carcinoid syndrome. Neuroendocrinology. 2004;80
Suppl 1:67-73. Review.
5. Barber FD, Mavligit G, Kurzrock R.: Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise
overview. Cancer Treat Rev. 2004 Aug;30(5):425-36. Review.
6. Blouin P, Brugieres L, Tabone MD, Leverger G, Rubie H, Branchereau S, De Kraker J.: Carboplatin-epirubicin
regimen for the treatment of hepatoblastoma. Pediatr Blood Cancer. 2004 Feb;42(2):149-54. Review.
7. Candeil L, Gourdier I, Peyron D, Vezzio N, Copois V, Bibeau F, Orsetti B, Scheffer GL, Ychou M, Khan QA,
Pommier Y, Pau B, Martineau P, Del Rio M.: ABCG2 overexpression in colon cancer cells resistant to SN38 and in
irinotecan-treated metastases. Int J Cancer. 2004 May 10;109(6):848-54.
8. Carlo WF, Hummer AJ, Schwartz L, Sullivan D, Gonen M, Jarnagin W, Fong Y, Kemeny N.: Extent of hepatic
resection does not correlate with toxicity following adjuvant chemotherapy. J Surg Oncol. 2004 Aug 1;87(2):85-90.
9. Carr BI.: Hepatocellular carcinoma: current management and future trends. Gastroenterology. 2004 Nov;127(5 Suppl
1):S218-24. Review.
10. Chan R, Kerr D.: Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003.
Curr Opin Oncol. 2004 Jul;16(4):378-84. Review.
11. Chang JY, Ka WS, Chao TY, Liu TW, Chuang TR, Chen LT.: Hepatocellular carcinoma with intra-atrial tumor
thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology. 2004;67(3-4):320-6.
Review.
12. Chen HB, Huang Y, Dai DL, Zhang X, Huang ZW, Zhang QK, Wang HH, Zhang JS, Pan G.: Therapeutic effect of
transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer. Hepatobiliary
Pancreat Dis Int. 2004 Feb;3(1):55-7.
13. Copson E, McKendrick J, Hennessey N, Tung K, Mead GZ.: Liver metastases in germ cell cancer: defining a role for
surgery after chemotherapy. BJU Int. 2004 Sep;94(4):552-8.
14. Coverdale SA, Khan MH, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Liddle C, Kench JG, Crewe E,
Farrell GC.: Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up
study. Am. J. Gastroenterol. 2004 Apr;99(4):636-44. Review.
15. Date M, Fukuchi K, Namiki Y, Okumura A, Morita S, Takahashi H, Ohura K.: Therapeutic effect of photodynamic
therapy using PAD-S31 and diode laser on human liver cancer cells. Liver Int. 2004 Apr;24(2):142-8.
16. Dawson LA, Lawrence TS.: The role of radiotherapy in the treatment of liver metastases. Cancer J. 2004 MarApr;10(2):139-44.
Review.
17. de Wilt JH, van Etten B, Verhoef C, Eggermont AM.: Isolated hepatic perfusion: experimental evidence and clinical
utility. Surg Clin North Am. 2004 Apr;84(2):627-41. Review.
18. Dobrzanski P, Hunter K, Jones-Bolin S, Chang H, Robinson C, Pritchard S, Zhao H, Ruggeri B.: Antiangiogenic
and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 2004 Feb 1;64(3):910-9.
19. Drevs J, Fakler J, Eisele S, Medinger M, Bing G, Esser N, Marme D, Unger C.: Antiangiogenic potency of various
chemotherapeutic drugs for metronomic chemotherapy. Anticancer Res. 2004 May-Jun;24(3a):1759-63.
20. Duenas-Carrera S.: DNA vaccination against hepatitis C. Curr Opin Mol Ther. 2004 Apr;6(2):146-50. Review.
21. Elaraj DM, Alexander HR.: Current role of hepatic artery infusion and isolated liver perfusion for the treatment of
colorectal cancer liver metastases. Cancer J. 2004 Mar-Apr;10(2):128-38. Review.
22. van Etten B, Brunstein F, van IJken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de
Bruijn EA, de Wilt JH, Eggermont AM.: Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in
patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study. Ann.
Surg. Oncol. 2004 Jun;11(6):598-605.
23. Fakih M.: First-line hepatic infusion of pirarubicin in patients with isolated liver metastases: is it really promising? Ann.
Oncol. 2004 Feb;15(2):359.
24. Fakih MG.: 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe
liver dysfunction. Oncology. 2004;67(3-4):222-4.
25. Fiorentini G, Rossi S, Bonechi F, Vaira M, De Simone M, Dentico P, Bernardeschi P, Cantore M, Guadagni S.: Intraarterial
hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study. J Chemother. 2004
Jun;16(3):293-7.
26. Fiorentini G, Rossi S, Dentico P, Meucci F, Bonechi F, Bernardeschi P, Cantore M, Guadagni S, De Simone M.:
Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical
study. Anticancer Res. 2004 May-Jun;24(3b):2093-6.
27. Furukawa S.: In vitro chemosensitivity of hepatocellular carcinoma for hepatic combinations of antitumor drugs.
Kurume Med J. 2004;51(1):25-33.
28. Garcea G, Lloyd TD, Gescher A, Dennison AR, Steward WP, Berry DP.: Angiogenesis of gastrointestinal tumours and
their metastases- a target for intervention? Eur J Cancer. 2004 Jun;40(9):1302-13. Review.
29. Garcea G, Polemonivi N, O’Leary E, Lloyd TD, Dennison AR, Berry DP.: Two-stage liver resection and chemotherapy
for bilobar colorectal liver metastases. Eur J Surg Oncol. 2004 Sep;30(7):759-64.
30. Gardini A, Ercolani G, Riccobon A, Ravaioli M, Ridolfi L, Flamini E, Ridolfi R, Grazi GL, Cavallari A, Amadori
D.: Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic
resection for colorectal liver metastases: 5-year analysis. J Surg Oncol. 2004 Jul 15;87(1):46-52.
31. Goldberg SR, Neifeld JP.: Incidentally discovered gallbladder cancer: role of cryotherapy. J Surg Oncol. 2004 Aug
1;87(2):91-4.
32. Granito A, Ballardini G, Fusconi M, Volta U, Muratori P, Sambri V, Battista G, Bianchi FB.: A case of leptospirosis
simulating colon cancer with liver metastases. World J Gastroenterol. 2004 Aug 15;10(16):2455-6.
33. Grobmyer SR, Fong Y, D’Angelica M, Dematteo RP, Blumgart LH, Jarnagin WR.: Diagnostic laparoscopy prior to
planned hepatic resection for colorectal metastases. Arch. Surg. 2004 Dec;139(12):1326-30.
34. Hawksworth J, Geisinger K, Zagoria R, Kavanagh P, Howerton R, Levine EA, Shen P.: Surgical and ablative
treatment for metastatic adenocarcinoma to the liver from unknown primary tumor. Am Surg. 2004 Jun;70(6):512-7.
35. Heriot AG, Reynolds J, Marks CG, Karanjia N.: Hepatic resection for colorectal metastases ─ a national perspective.
Ann. R. Coll. Surg. Engl. 2004 Nov;86(6):420-4.
36. Hillenbrand A, Formentini A, Staib L, Sander S, Salonga D, Danenberg K, Danenberg P, Kornmann M.: A
longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving
hepatic arterial infusion chemotherapy. Eur J Surg Oncol. 2004 May;30(4):407-13.
37. Ishii H, Furuse J, Nagase M, Yoshino M, Kawashima M, Satake M, Ogino T, Ikeda H.: Hepatic arterial infusion of 5-
fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma. Hepatogastroenterology. 2004
Jul-Aug;51(58):1175-8.
38. Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.: Therapeutic efficacy of multimodal
combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil,
and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol.
2004 Nov;54(5):415-20.
39. Kanai T, Takabayashi T, Kawano Y, Kuramochi S, Miyazawa N.: A case of postoperative recurrence of fibrolamellar
hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female. Jpn J Clin Oncol.
2004 Jun;34(6):346-51.
40. Kanbay M, Gur G, Korkmaz M, Demirci B, Boyacioglu S.: Hepatic lymphoma metastasis presenting with severe acute
liver failure: a rare case. Turk J Gastroenterol. 2004 Jun;15(2):94-6.
41. Kaneko F, Saito H, Saito Y, Wakabayashi K, Nakamoto N, Tada S, Suzuki H, Tsunematsu S, Kumagai N, Ishii H.:
Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase
inhibitor sodium butyrate. Int J Oncol. 2004 Apr;24(4):837-45.
42. Khatri VP, McGahan J.: Non-resection approaches for colorectal liver metastases. Surg Clin North Am. 2004
Apr;84(2):587-606. Review.
43. Libra M, Navolanic PM, Talamini R, Cecchin E, Sartor F, Tumolo Toffoli G.: Thymidylate synthetase mRNA levels
are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy. BMC
Cancer. 2004 Mar 25;4(1):11.
44. Lim YP, Wong CY, Ooi LL, Druker BJ, Epstein RJ.: Selective tyrosine hyperphosphorylation of cytoskeletal and stress
proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs. Clin Cancer Res.
2004 Jun 15;10(12 Pt 1):3980-7.
45. Lin CC, Ng LT, Hsu FF, Shieh DE, Chiang LC.: Cytotoxic effects of Coptis chinensis and Epimedium sagittatum
extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. Clin Exp
Pharmacol Physiol. 2004 Jan-Feb;31(1-2):65-9.
46. Lygidakis NJ, Singh G, Bardaxoglou E, Dedemadi G, Sgourakis G, Nestoridis J, Malliotakis A, Pedonomou M,
Solomou EK, Safioleas M, Alamani M, Grigorakos L, Merikas EM.: Two-stage liver surgery for advanced liver
metastasis synchronous with colorectal tumor. Hepatogastroenterology. 2004 Mar-Apr;51(56):413-8.
47. Machiavelli MR, Salum G, Perez JE, Ortiz EH, Romero AO, Bologna F, Vallejo CT, Lacava JA, Dominguez ME,
Leone BA.: Double modulation of 5-fluorouracil by trimetrexate and leucovorin in patients with advanced colorectal
carcinoma. Am J Clin Oncol. 2004 Apr;27(2):149-54.
48. Matsuno N, Nakamura Y, Iwamoto H, Hama K, Akashi I, Konno S, Jojima Y, Uchiyama M, Nagao T.:
Radiofrequency ablation of unresectable hepatic malignancies. Chirurgia (Bucur). 2004 Jul-Aug;99(4):205-10.
49. Melichar B, Voboril Z, Cerman J Jr, Melicharova K, Nozicka J, Mergancova J, Voboril R, Jandik P.: Hepatic
arterial infusion chemotherapy in gastric cancer: a report of four cases and analysis of the literature. Tumori. 2004 JulAug;90(4):428-34.
Review.
50. Mok TS, Leung TW, Brown G, Moyses C, Chan AT, Yeo W, Wong H, Chak K, Johnson P.: A phase I safety and
pharmacokinetic study of OGT 719 in patients with liver cancer. Acta Oncol. 2004;43(3):245-51.
51. Morise Z, Yamafuji K, Asami A, Takeshima K, Hayashi N, Baba H, Endo T, Hattori T, Ito Y, Tokura Y.:
Hepatectomy following transarterial chemotherapy for a metastasis in the caudate lobe. Hepatogastroenterology. 2004
Mar-Apr;51(56):583-5.
52. Nelson R, Freels S.: Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer
metastatic to the liver. Cochrane Database Syst Rev. 2004;(2):CD003770. Review.
53. Nelson RL, Freels S.: A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer
metastatic to the liver. Dis Colon Rectum. 2004 May;47(5):739-45. Epub 2004 Mar 25. Review.
54. Nowak A, Findlay M, Culjak G, Stockler M.: Tamoxifen for hepatocellular carcinoma. Cochrane Database Syst Rev.
2004;(3):CD001024. Review.
55. Oberfield RA, Sampson E, Heatley GJ.: Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the
liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement.
Am J Clin Oncol. 2004 Aug;27(4):376-83.
56. Okaji Y, Tsuno NH, Kitayama J, Saito S, Takahashi T, Kawai K, Yazawa K, Asakage M, Hori N, Watanabe T,
Shibata Y, Takahashi K, Nagawa H.: Vaccination with autologous endothelium inhibits angiogenesis and metastasis of
colon cancer through autoimmunity. Cancer Sci. 2004 Jan;95(1):85-90.
57. Ota M, Shimada H, Masui H, Tanaka K, Yamaguchi S, Ichikawa Y, Togo S, Ike H, Oki S.: Adjuvant hepatic arterial
infusion chemotherapy after curative resection for Dukes C colorectal cancer: a pilot study. Hepatogastroenterology.
2004 Jan-Feb;51(55):124-7.
58. O’Toole D, Hentic O, Corcos O, Ruszniewski P.: Chemotherapy for gastro-enteropancreatic endocrine tumours.
Neuroendocrinology. 2004;80 Suppl 1:79-84. Review.
59. Palmer DH, Mautner V, Mirza D, Oliff S, Gerritsen W, van der Sijp JR, Hubscher S, Reynolds G, Bonney S,
Rajaratnam R, Hull D, Horne M, Ellis J, Mountain A, Hill S, Harris PA, Searle PF, Young LS, James ND, Kerr
DJ.: Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding
nitroreductase to patients with resectable liver cancer. J Clin Oncol. 2004 May 1;22(9):1546-52. Epub 2004 Mar 29.
60. Peyregne V, Quash G, Isaac S, Chantepie J, Akiba H, Scoazec JY, Gilly FN.: Survival after gamma interferon
intratumoral injections in a model of hepatocarcinoma. Hepatogastroenterology. 2004 Jul-Aug;51(58):1115-20.
61. Pohlen U, Mansmann U, Berger G, Germer CT, Gallkowski U, Boese-Landgraf J, Buhr HJ.: Multicenter pilot study
of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in
patients with nonresectable colorectal liver metastases. Anticancer Res. 2004 Sep-Oct;24(5B):3275-82.
62. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, Vellone M, Giuliante F, Nuzzo G, Barone C.:
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer
patients. Ann. Oncol. 2004 Jun;15(6):933-9.
63. Ramadori G, Fuzesi L, Grabbe E, Pieler T, Armbrust T.: Successful treatment of hepatocellular carcinoma with the
tyrosine kinase inhibitor imatinib in a patient with liver cirrhosis. Anticancer Drugs. 2004 Apr;15(4):405-9.
64. van Riel JM, van Groeningen CJ, de Greve J, Gruia G, Pinedo HM, Giaccone G.: Continuous infusion of hepatic
arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann. Oncol. 2004 Jan;15(1):59-63.
65. Rothbarth J, Tollenaar RA, Schellens JH, Nortier JW, Kool LJ, Kuppen PJ, Mulder GJ, van de Velde CJ.: Isolated
hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives. Eur J
Cancer. 2004 Aug;40(12):1812-24. Review.
66. Ruan DT, Warren RS.: Palliative techniques for hepatic cancer. Surg Oncol Clin N Am. 2004 Jul;13(3):505-16, ix.
Review.
67. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane
O, Chaussade S, Mentha G, Terris B.: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based
chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 2004 Mar;15(3):460-6.
68. Ruszniewski P, O’Toole D.: Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
Neuroendocrinology. 2004;80 Suppl 1:74-8. Review.
69. Sadahiro S, Suzuki T, Ishikawa K, Yasuda S, Tajima T, Makuuchi H, Saitoh T, Murayama C.: Prophylactic hepatic
arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized
control trial. Cancer. 2004 Feb 1;100(3):590-7.
70. Sahani DV, Krishnamurthy SK, Kalva S, Cusack J, Hahn PF, Santilli J, Saini S, Mueller PR.: Multidetector-row
computed tomography angiography for planning intra-arterial chemotherapy pump placement in patients with colorectal
metastases to the liver. J Comput Assist Tomogr. 2004 Jul-Aug;28(4):478-84.
71. Sakai M, Miyake H, Tashiro S, Okumura Y, Kido H.: Inhibitory effect of FK506 and cyclosporine A on the growth and
invasion of human liver cancer cells. J Med Invest. 2004 Feb;51(1-2):63-9.
72. Shibata C, Jin XL, Funayama Y, Fukushima K, Takahashi K, Hashimoto A, Nagao M, Haneda S, Watanabe K,
Matsuno S, Sasaki I, Naito H.: Effect of intra-arterial cisplatin on multiple liver metastases from rectal cancer associated
with ulcerative colitis. Tohoku J Exp Med. 2004 Jan;202(1):57-61.
73. Shimada H, Tanaka K, Masui H, Nagano Y, Matsuo K, Kijima M, Ichikawa Y, Ike H, Ooki S, Togo S.: Results of
surgical treatment for multiple (> or =5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch.
Surg. 2004 Apr;389(2):114-21. Epub 2004 Jan 09.
74. Shirabe K, Shimada M, Tsujita E, Aishima S, Maehara S, Tanaka S, Takenaka K, Maehara Y.: Prognostic factors in
node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am. J. Surg. 2004
Apr;187(4):538-42.
75. Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F,
Pascale RM.: Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression
of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis. 2004 Mar;25(3):333-41.
Epub 2003 Nov 06.
76. Steel J, Baum A, Carr B.: Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial
infusion of Cisplatin versus 90-Yttrium microspheres (Therasphere). Psychooncology. 2004 Feb;13(2):73-9.
77. Sutcliffe R, Maguire D, Ramage J, Rela M, Heaton N.: Management of neuroendocrine liver metastases. Am. J. Surg.
2004 Jan;187(1):39-46. Review.
78. Takamatsu S, Teramoto K, Kawamura T, Kudo A, Noguchi N, Irie T, Ochiai T, Kumagai J, Koike M, Arii S.: Liver
metastasis from rectal cancer with prominent intrabile duct growth. Pathol Int. 2004 Jun;54(6):440-5.
79. Teoh NC, Farrell GC.: Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J.
2004 Jun;34(6):324-37. Review.
80. Thomas KT, Bream PR Jr, Berlin J, Meranze SG, Wright JK, Chari RS.: Use of percutaneous drainage to treat
hepatic abscess after radiofrequency ablation of metastatic pancreatic adenocarcinoma. Am Surg. 2004 Jun;70(6):496-9.
81. Tono T, Kanoh T, Ohnishi T, Matsushita M, Nakano Y, Kimura Y, Iwazawa T, Yano H, Okamura J, Monden T.:
Adjuvant hepatic arterial infusion after curative resection of colorectal liver metastases using removable intra-arterial
catheters with shape-memory alloy. J Surg Oncol. 2004 Dec 15;88(4):248-55.
82. Towu E, Kiely E, Pierro A, Spitz L.: Outcome and complications after resection of hepatoblastoma. J Pediatr Surg.
2004 Feb;39(2):199-202; discussion 199-202. Review.
83. Tran TH, Pathak RD, Basa AL.: Metastatic insulinoma: case report and review of the literature. South Med J. 2004
Feb;97(2):199-201. Review.
84. Ueno H, Mochizuki H, Hashiguchi Y, Hatsuse K, Fujimoto H, Hase K.: Predictors of extrahepatic recurrence after
resection of colorectal liver metastases. Br. J. Surg. 2004 Mar;91(3):327-33.
85. Wen J, Matsumoto K, Taniura N, Tomioka D, Nakamura T.: Hepatic gene expression of NK4, an HGFantagonist/angiogenesis
inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. Cancer Gene
Ther. 2004 Jun;11(6):419-30.
86. Wray CJ, Rilo HL, Ahmad SA.: Colon cancer angiogenesis and antiangiogenic therapy. Expert Opin Investig Drugs.
2004 Jun;13(6):631-41. Review.
87. Yamagami T, Kato T, Iida S, Hirota T, Nishimura T.: Interventional radiologic treatment for hepatic arterial occlusion
after repeated hepatic arterial infusion chemotherapy via implanted port-catheter system. J Vasc Interv Radiol. 2004
Jun;15(6):633-9.
88. Yamagami T, Kato T, Iida S, Tanaka O, Nishimura T.: Value of transcatheter arterial embolization with coils and nbutyl
cyanoacrylate for long-term hepatic arterial infusion chemotherapy. Radiology. 2004 Mar;230(3):792-802. Epub
2004 Jan 22.
89. Yang ZW, Xu GL.: Isolated hepatic perfusion: a regional therapy for liver cancer. Hepatobiliary Pancreat Dis Int. 2004
Feb;3(1):12-6. Review.
90. Yeh CN, Jan YY, Chen MF.: Influence of age on surgical treatment of peripheral cholangiocarcinoma. Am. J. Surg. 2004
Apr;187(4):559-63.
91. Zhu AL, Liu LX, Piao DX, Lin YX, Zhao JP, Jiang HC.: Liver regional continuous chemotherapy: use of femoral or
subclavian artery for percutaneous implantation of catheter-port systems. World J Gastroenterol. 2004 Jun
1;10(11):1659-62.
92. Zuo CJ, Wang PJ, Shao CW, Wang MJ, Tian JM, Xiao Y, Ren FY, Hao XY, Yuan M.: CT-guided percutaneous
ethanol injection with disposable curved needle for treatment of malignant liver neoplasms and their metastases in
retroperitoneal lymph nodes. World J Gastroenterol. 2004 Jan;10(1):58-61.
